Copland, M. , Hamilton, A., Baird, J., Barow, M., Allan, E., Elrick, L. and Holyoake, T. (2005) Dasatinib (BMS-354825) has increased activity against Bcr-Abl compared to imatinib in primary CML cells in vitro, but does not eradicate quiescent CML stem cells. Blood, 106(11), 205A-205A.
Full text not currently available from Enlighten.
| Item Type: | Articles |
|---|---|
| Status: | Published |
| Refereed: | Yes |
| Glasgow Author(s) Enlighten ID: | Copland, Professor Mhairi |
| Authors: | Copland, M., Hamilton, A., Baird, J., Barow, M., Allan, E., Elrick, L., and Holyoake, T. |
| College/School: | College of Medical Veterinary and Life Sciences > School of Cancer Sciences |
| Journal Name: | Blood |
University Staff: Request a correction | Enlighten Editors: Update this record
Deposit and Record Details
Deposit and Record Details